Heart Rhythm Society and Milestone Pharmaceuticals Partner to Expand SVT Patient Education Through UpBeat.org

Longitude Health names Colin Drylie as COO of Longitude FX

West Appoints Michel Lagarde to be President and Chief Executive Officer

HelloNation Explains Moving to Western Kentucky With Insights From Real Estate Expert Leslie Heath

Keenova Champions Men's Health Month with Education and Outreach

Cirius Therapeutics Announces Presentation on CIR-0602K as Novel Diabetes Treatment at the American Diabetes Association's 2026 Scientific Sessions

SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION

ZIEGLER CLOSES $41,200,000 FINANCING FOR CHRISTIAN LIVING COMMUNITIES (CO)

Novavax to Participate in 2026 Jefferies Global Healthcare Conference

EUROPEAN COMMISSION APPROVES AMGEN'S IMDYLLTRA® FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER

Oculis Holding AG Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Oculis Holding AG (OCS)

Starlight Children's Foundation Celebrates Play Week and Rallies Communities to Deliver Happiness to Hospitalized Kids

Blue Shield of California Warns Consumers About Medicare Fraud and Scams

5 Facts About Health Savings Accounts (HSAs) and Newly Released IRS 2027 HSA Contribution Limits from the Experts at HSA Store®

Perceptive Discovery and Certis Oncology Announce Strategic Collaboration to Advance Radiopharmaceutical Development

Solv Wellness Partners with Mia Syn, MS, RDN, to Help Women Navigate Menopause Supplements

American Nephrology Nurses Association Announces 2026 Advocacy Forum

Meet Skylight Buddy: A First-of-Its-Kind Device Designed to Help Kids Own Their Day

Oncology Claims: June Malpractice Risk Review--Insights to Reduce Patient Harm and Malpractice Exposure

Patent 12,640,242 Fuels Xact Labs' Genetic Data Integration

UCB Launches Career-Advancing Scholarship Program for Adults Living with Hidradenitis Suppurativa and Immediate Family Members

Ansun Biopharma Announces Independent Data Monitoring Committee Recommendation Supporting Continued Phase 3 Development of DAS181 in Immunocompromised Patients with Parainfluenza Infection

IDEAYA Biosciences and Servier Provide Complete Data from Phase 2/3 Registrational OptimUM-02 Trial of the Darovasertib Combination in First Line HLA*A2:01 Negative Metastatic Uveal Melanoma in a Late-Breaking Oral Presentation at ASCO

The CareBridge Group Announces $91 Million Corporate Master Grant to Launch the "Community Access Coalition" Across Florida

Made Scientific Selected as Manufacturer for Columbia University's Autologous and Allogeneic NOVAKnee Program - a First-in-Class Living Biologic Total Knee Replacement

Connect Life Sciences Appoints Megan Driscoll as Executive Chairman of the Board

BIOMERICS APPOINTS LIRAN AVIGAD GREINER AS PRESIDENT OF INTERNATIONAL DIVISION IN COSTA RICA

SCHLESINGER LAW OFFICES SECURES $6.4 MILLION MEDICAL MALPRACTICE VERDICT IN AMPUTATION CASE

Men's Health Month Highlights Urgent Need for Rural Healthcare Access in Illinois

Servier projette d'acquérir l'activité dystrophie musculaire d'Edgewise Therapeutics